GLP-1 Drugs Under Scrutiny for Athletic Use
As public figures share their weight-loss journeys, officials are monitoring GLP-1 use among elite athletes.
Updated on Sept. 28, 2026 in Weight Loss
Live Poll
Should GLP-1 weight-loss drugs be classified as performance-enhancing substances in professional sports?
Serena Williams recently disclosed using a GLP-1 drug, fueling wider discussions about the prevalence of these medications among elite competitors. Approximately 15% of the U.S. population now uses these drugs for various health reasons.
Why it matters
Researchers are currently investigating whether GLP-1 medications offer performance advantages to athletes, prompting sports regulators to closely watch usage trends. This ensures that doping policies remain evidence-based as the drugs become more common globally.
A study of sports medicine physicians found that 12% were aware of elite athletes using GLP-1s without a medical requirement. Researchers are now working to determine if these drugs provide any distinct physiological benefit to high-performance athletes.
The players
Serena Williams
A world-renowned professional athlete who recently shared her experience with GLP-1 medication.
World Anti-Doping Association
The global body responsible for regulating performance-enhancing substances and anti-doping policies in professional sports.
Loughborough University
A British research institution that conducted a survey of sports medicine physicians regarding the use of GLP-1 drugs.
The details
GLP-1 drugs work by mimicking hormones that signal fullness and regulate blood sugar, leading to reduced calorie intake. While Serena Williams reported losing 34 pounds over one year using these treatments, the potential effects on muscle recovery or cardiovascular endurance in competitive sports remain poorly understood. Because of these unknowns, sports organizations are moving to track usage patterns more effectively.
Timeline
2024: The World Anti-Doping Association added GLP-1s to its monitoring list.
September 27, 2026: Researchers published findings regarding GLP-1 use among athletes.
Health Landscape
This scrutiny follows the established precedent of the World Anti-Doping Association Prohibited List, which strictly regulates chemical influence on athletic performance. The current monitoring of GLP-1s marks a shift as regulators assess whether these medications cross the line from clinical treatment into performance enhancement.
If you are considering a GLP-1 medication for weight management, consult your primary physician to discuss the potential side effects and your individual health profile. Be aware that these drugs are prescription-only and are intended for patients with a documented medical need.
The takeaway
While GLP-1 drugs have become common for weight management, their effect on physical performance is still being studied by medical professionals. If you are a competitive athlete or frequently participate in organized sports, discuss any prescribed medications with a sports medicine specialist to ensure compliance with relevant regulations.
Further reading
For more on the implications of pharmacological weight management, see our guide on Weight Loss.
Source note: This article includes information reported by Sportsbusinessjournal.
Live Poll
Should GLP-1 weight-loss drugs be classified as performance-enhancing substances in professional sports?
